[1]
“Alirocumab post-acute coronary syndrome: An integrative review on treatment and its influence on future cardiovascular and metabolic complications ”, RSD, vol. 14, no. 1, p. e8914147973, Jan. 2025, doi: 10.33448/rsd-v14i1.47973.